98%
921
2 minutes
20
A dual-stage model for classifying Parkinson's disease severity, through a detailed analysis of Gait signals using force sensors and machine learning approaches, is proposed in this study. Parkinson's disease is the primary neurodegenerative disorder that results in a gradual reduction in motor function. Early detection and monitoring of the disease progression is highly challenging due to the gradual progression of symptoms and the inadequacy of conventional methods in identifying subtle changes in mobility. The proposed dual-stage model utilized a hypertuned Random Forest Tree (RFT) to classify the subjects into PD and non-PD classes at Stage 1 and a hypertuned Ensemble Regressor (ER) to predict the severity of illness at Stage 2. Further, we have implemented the proposed model on the data signals gathered from both feet of 166 participants using Vertical Ground Reaction Force Sensors (VGRF). The dataset comprised 93 persons with Parkinson's disease and 73 healthy controls. The dataset (imbalance) collected from both feet is passed to the preprocessing phase (for balancing data using the SMOTE method), followed by the feature extraction phase to extract features related to time, frequency, spatial, and temporal features domains that are highly effective for detecting and assigning severity levels of PD. A Recursive Feature Elimination method is also used to select the optimal set of features to improve the model performance. It is acknowledged that the early detection of Parkinson's disease is contingent upon critical parameters, including stride length, stance duration, swing interval, double limb support, step time, and step length. The crucial evaluation metrics used for evaluating model performance include accuracy, mean absolute error, and root mean square error. The findings indicate that the suggested model significantly surpasses current methodologies. It attained an accuracy of 97.5 ± 2.1%, Sensitivity of 97% ± 2.5%, and average Specificity of 95% ± 2.2% in differentiating between PD and non-PD participants utilizing RFT and evaluated disease severity with an average accuracy of 96.4 ± 2.3%, an average mean absolute error of 0.065 ± 0.024, and a root mean square error of 0.080 ± 0.06. The results indicate that the proposed dual-stage model is exceptionally successful in the early detection and severity assessment of Parkinson's disease and demonstrates better efficacy than alternative models.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11696931 | PMC |
http://dx.doi.org/10.1038/s41598-024-83357-9 | DOI Listing |
Comput Methods Biomech Biomed Engin
September 2025
Institute of Radio Physics and Electronics, University of Calcutta, Kolkata, India.
Parkinson's disease (PD) is a neurodegenerative condition that impairs motor functions. Accurate and early diagnosis is essential for enhancing well-being and ensuring effective treatment. This study proposes a deep learning-based approach for PD detection using EEG signals.
View Article and Find Full Text PDFInt J Plant Anim Environ Sci
August 2025
Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
Neurological disorders, such as Alzheimer's disease, Parkinson's disease, epilepsy, spinal cord injuries, and traumatic brain injuries, represent substantial global health challenges due to their chronic and often progressive nature. While allopathic medicine offers a range of pharmacological interventions aimed at managing symptoms and mitigating disease progression, it is accompanied by limitations, including adverse side effects, the development of drug resistance, and incomplete efficacy. In parallel, phytochemicals-bioactive compounds derived from plants-are receiving increased attention for their potential neuroprotective, antioxidant, and anti-inflammatory properties.
View Article and Find Full Text PDFFront Microbiol
August 2025
Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
Background: Increasing evidence suggests a potential role of the gut microbiota in Parkinson's disease (PD). However, the relationship between the gut microbiome (GM) and PD dementia (PDD) remains debated, with their causal effects and underlying mechanisms not yet fully understood.
Methods: Utilizing data from large-scale genome-wide association studies (GWASs), this study applied bidirectional and mediating Mendelian randomization (MR) to investigate the causal relationship and underlying mechanisms between the GM and PDD.
Parkinsons Dis
September 2025
Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne, UK.
Cognitive impairment in Parkinson's disease (PD) is common, but there is scarce evidence as to how this group of patients can be most effectively assessed and managed. Our quality improvement project evaluated the impact of integrating a PD specialist psychiatrist (PDSP) into an existing multidisciplinary team (MDT) to allow direct referral of patients with cognitive impairment rather than to a separate service. We collected data over 1 year to map the referral trajectories of patients through the new pathway and estimated cost savings by comparison with the previous pathway.
View Article and Find Full Text PDFBeilstein J Org Chem
August 2025
A. N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, INEOS, Vavilova St. 28, Moscow, 119334, Russia.
Reducing agents with phosphorus-hydrogen bond, such as sodium hypophosphite, phosphite, and hypophosphorous acid are commercially available in bulk amounts, however, their usage is understudied in organic processes. While NaHPO has proved to be an efficient four-electron reductant in the catalyst-free reductive amination, the influence of cation in hypophosphite salt has not been studied yet. This issue is a fundamentally important factor.
View Article and Find Full Text PDF